{"id":1177009,"date":"2026-09-09T14:39:12","date_gmt":"2026-09-09T14:39:12","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/1177009\/"},"modified":"2026-09-09T14:39:12","modified_gmt":"2026-09-09T14:39:12","slug":"pour-la-premiere-fois-de-ma-carriere-des-patients-me-disent-quils-sont-gueris-enfin-un-traitement-efficace-contre-la-narcolepsie","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/1177009\/","title":{"rendered":"\u00ab\u00a0Pour la premi\u00e8re fois de ma carri\u00e8re, des patients me disent qu\u2019ils sont gu\u00e9ris\u00a0\u00bb\u00a0: enfin un traitement efficace contre la narcolepsie"},"content":{"rendered":"

\n Par
\nDelphine Chayet<\/a><\/p>\n

Publi\u00e9 le 09\/09\/2026 \u00e0 14h01, mis \u00e0 jour le 09\/09\/2026 \u00e0 15h51<\/p>\n

Loin d\u2019\u00eatre anodine, la narcolepsie va entra\u00eener des cons\u00e9quences n\u00e9fastes sur la scolarit\u00e9 et la vie professionnelle.
\n STOCK ADOBE<\/p>\n

\n L\u2019oveporexton r\u00e9duit la somnolence chez les personnes atteintes du type\u00a01 de la maladie. Alors que l\u2019agence du m\u00e9dicament am\u00e9ricaine a approuv\u00e9 le produit en ao\u00fbt, les patients esp\u00e8rent qu\u2019il en sera de m\u00eame en Europe.<\/p>\n

Risquer de s\u2019endormir \u00e0 tout moment, y compris en pleine activit\u00e9\u00a0; avoir des hallucinations au r\u00e9veil\u00a0; se transformer en \u00ab\u00a0poup\u00e9e de chiffon\u00a0\u00bb apr\u00e8s un \u00e9clat de rire\u2026\u00a0La narcolepsie de type\u00a01<\/a>\u00a0est consid\u00e9r\u00e9e comme le plus invalidant des troubles du sommeil.<\/strong> \u00ab\u00a0Les \u00e9motions positives entra\u00eenent chez ces patients une perte de la force musculaire (la cataplexie), relate le Pr\u00a0Yves Dauvilliers, responsable de l\u2019\u00e9quipe\u00a0des troubles du sommeil<\/a>\u00a0et de l\u2019\u00e9veil au CHU de Montpellier. On peut tomber, ou voir sa t\u00eate basculer en avant, ses bras et ses genoux fl\u00e9chir pendant quelques secondes.\u00a0\u00bb<\/p>\n

Pour les 20\u00a0000\u00a0personnes souffrant de cette maladie rare en France, les r\u00e9sultats de deux essais cliniques publi\u00e9s mercredi\u00a0dans la revue New England Journal of Medicine<\/a> \u00a0constituent un tournant. L\u2019\u00e9tude montre l\u2019efficacit\u00e9 d\u2019un nouveau m\u00e9dicament, l\u2019oveporexton, pour r\u00e9duire la somnolence et la fr\u00e9quence des \u00e9pisodes de cataplexie. \u00ab\u00a0Le traitement a produit un effet imm\u00e9diat qui a persist\u00e9 pendant\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 82% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vente Flash<\/p>\n

-70% sur votre abonnement. Sans engagement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"Par Delphine Chayet Publi\u00e9 le 09\/09\/2026 \u00e0 14h01, mis \u00e0 jour le 09\/09\/2026 \u00e0 15h51 Loin d\u2019\u00eatre anodine,…\n","protected":false},"author":2,"featured_media":1177010,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[10],"tags":[1011,27,72,122101,71,279],"class_list":["post-1177009","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-fr","tag-france","tag-health","tag-narcolepsie","tag-sante","tag-sommeil"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/117241601392183661","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1177009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=1177009"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1177009\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/1177010"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=1177009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=1177009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=1177009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}